Brain-derived neurotrophic factor (BDNF) is not related to climacteric symptoms in healthy women: a cross-sectional study

Maturitas ◽  
2019 ◽  
Vol 124 ◽  
pp. 171
Author(s):  
Fernanda Vargas Ferreira ◽  
Charles Francisco Ferreira ◽  
Mona Lúcia Dall’Agno ◽  
Jéssica Zandoná ◽  
Joana Zanotti ◽  
...  
Keyword(s):  
Neurotrophic Factor ◽  
Brain Derived Neurotrophic Factor ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Climacteric Symptoms ◽  
Cross Sectional ◽  
Healthy Women

Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia – A controlled cross-sectional study

Cytokine ◽  
2016 ◽  
Vol 84 ◽  
pp. 25-28 ◽  
Author(s):  
Aline Ranzolin ◽  
Angela Luzia Branco Pinto Duarte ◽  
Markus Bredemeier ◽  
Cláudio Antônio da Costa Neto ◽  
Bruna Maria Ascoli ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Neurotrophic Factor ◽  
Brain Derived Neurotrophic Factor ◽  
Cross Sectional Study ◽  
Oxidative Stress Markers ◽  
Sectional Study ◽  
Cross Sectional ◽  
Stress Markers

Association between brain-derived neurotrophic factor (BDNF) level and perceptual thresholds in middle-aged women: a cross-sectional study

Maturitas ◽  
2019 ◽  
Vol 124 ◽  
pp. 170-171
Author(s):  
Fernanda Vargas Ferreira ◽  
Charles Francisco Ferreira ◽  
Mona Lúcia Dall’Agno ◽  
Jéssica Zandoná ◽  
Joana Zanotti ◽  
...  
Keyword(s):  
Neurotrophic Factor ◽  
Brain Derived Neurotrophic Factor ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Middle Aged ◽  
Bdnf Level ◽  
Cross Sectional

scholarly journals Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study

2020 ◽  
Vol 16 (5) ◽  
pp. 1049-1056
Author(s):  
Jan K. Nowak ◽  
Mariusz Szczepanik ◽  
Magdalena Trypuć ◽  
Andrzej Pogorzelski ◽  
Waldemar Bobkowski ◽  
...  
Keyword(s):  
Cystic Fibrosis ◽  
Neuropeptide Y ◽  
Neurotrophic Factor ◽  
Brain Derived Neurotrophic Factor ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Cross Sectional ◽  
Clinical Correlates

scholarly journals Peripheral Brain-Derived Neurotrophic Factor and Contactin-1 Levels in Patients with Attention-Deficit/Hyperactivity Disorder

2019 ◽  
Vol 8 (9) ◽  
pp. 1366 ◽  
Author(s):  
Liang-Jen Wang ◽  
Chih-Ching Wu ◽  
Min-Jing Lee ◽  
Miao-Chun Chou ◽  
Sheng-Yu Lee ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Neurotrophic Factor ◽  
Performance Test ◽  
Continuous Performance Test ◽  
Brain Derived Neurotrophic Factor ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Hyperactivity Disorder ◽  
Drug Naïve

Brain-derived neurotrophic factor (BDNF) facilitates neuronal growth and plasticity, and is crucial for learning and memory. Contactin-1 (CNTN1) is a member of the subfamily of neural immunoglobulin and is involved in the formation of axon connections in the developing nervous system. This cross-sectional study investigates whether BDNF and CNTN1 affect susceptibility to attention deficit/hyperactivity disorder (ADHD). A total of 136 drug-naïve patients with ADHD (108 boys and 28 girls) and 71 healthy controls (45 boys and 26 girls) were recruited. Blood samples were obtained to measure the plasma levels of BDNF and CNTN1 in each child. We found that BDNF levels in the ADHD boys exceeded those in the control boys, but BDNF levels in the ADHD girls were lower than those in the control girls. Boys who had higher BDNF levels performed worse on the Wechsler Intelligence Scale for Children—Fourth Edition, but girls who had higher BDNF levels made fewer omission errors in the Conners’ Continuous Performance Test. However, CNTN1 level did not differ significantly between patients and controls, and were not correlated to ADHD characteristics, regardless of gender. The findings suggest BDNF may influence sex-specific susceptibility to ADHD, but CNTN1 was not associated with ADHD pathophysiology.

Sign in / Sign up

Export Citation Format

Share Document